Title |
Ketogenic diet for epilepsy treatment
|
---|---|
Published in |
Arquivos de Neuro-Psiquiatria, October 2016
|
DOI | 10.1590/0004-282x20160116 |
Pubmed ID | |
Authors |
Letícia Pereira de Brito Sampaio |
Abstract |
The ketogenic diet (KD), a high-fat, low-carbohydrate, and adequate-protein diet is an established, effective nonpharmacologic treatment option for intractable childhood epilepsy. The KD was developed in 1921 and even though it has been increasingly used worldwide in the past decade, many neurologists are not familiar with this therapeutic approach. In the past few years, alternative and more flexible KD variants have been developed to make the treatment easier and more palatable while reducing side effects and making it available to larger group of refractory epilepsy patients. This review summarizes the history of the KD and the principles and efficacy of the classic ketogenic diet, medium-chain triglyceride(s) (MCT) ketogenic diet, modified Atkins diet, and low glycemic index treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 18% |
Canada | 1 | 9% |
South Africa | 1 | 9% |
Unknown | 7 | 64% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 73% |
Practitioners (doctors, other healthcare professionals) | 3 | 27% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 418 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 89 | 21% |
Student > Master | 38 | 9% |
Researcher | 20 | 5% |
Student > Doctoral Student | 17 | 4% |
Other | 16 | 4% |
Other | 58 | 14% |
Unknown | 180 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Nursing and Health Professions | 62 | 15% |
Medicine and Dentistry | 61 | 15% |
Biochemistry, Genetics and Molecular Biology | 30 | 7% |
Neuroscience | 18 | 4% |
Unspecified | 14 | 3% |
Other | 40 | 10% |
Unknown | 193 | 46% |